🔎 Trials Near Me

Dachaigh › Galar Ae Steatotic › Texas › Austin

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Austin, TX

Tha 13 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann agus timcheall air Austin (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

A’ fastadhÌre 2
  • American Research Corporation, Austin
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

A’ fastadhÌre 2
  • American Research Corporation, Austin
  • Pinnacle Clinical Research - Austin, Austin
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

A’ fastadhÌre 3
  • IMA Clinical Research Austin, Austin
  • American Research Corporation, Austin
  • Pinnacle Clinical Research, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

A’ fastadhÌre 3
  • Akero Clinical Study Site, Austin
  • Akero Clinical Study Site, Austin
  • Akero Clinical Study Site, Austin
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A’ fastadhÌre 3
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

A’ fastadhÌre 3
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06419374

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A’ fastadhÌre 2
  • GSK Investigational Site, Austin
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

A’ fastadhÌre 3
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

A’ fastadhÌre 2
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
  • GSK Investigational Site, Austin
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043

Sgrùdaidhean Galar Ae Steatotic ann am bailtean eile

Sgrùdaidhean eile ann an Austin

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.